Biolegend, 100713, APC/Cyanine7 anti-mouse CD8a Antibody, 25μg

CD8, also known as Lyt-2, Ly-2, or T8, consists of disulfide-linked α and β chains that form the α(CD8a)/β(CD8b) heterodimer and α/α homodimer. CD8a is a 34 kD protein that belongs to the immunoglobulin family. The CD8 α/β heterodimer is expressed on the surface of most thymocytes and a subset of mature TCR α/β T cells. CD8 expression on mature T cells is non-overlapping with CD4. The CD8 α/α homodimer is expressed on a subset of γ/δ TCR-bearing T cells, NK cells, intestinal intraepithelial lymphocytes, and lymphoid dendritic cells. CD8 is an antigen co-receptor on T cells that interacts with MHC class I on antigen-presenting cells or epithelial cells. CD8 promotes T cell activation through its association with the TCR complex and protein tyrosine kinase lck.
25μg
Verified Reactivity: Mouse
Antibody Type: Monoclonal
Host Species: Rat
Immunogen: Mouse thymus or spleen
Formulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation: The antibody was purified by affinity chromatography, and conjugated with APC/Cyanine7 under optimal conditions.
Concentration: 0.2 mg/ml
Storage & Handling: The CD8a antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application: FC - Quality tested
Recommended Usage: Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is =1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.
Excitation Laser: Red Laser (633 nm)
Application Notes: Clone 53-6.7 antibody competes with clone 5H10-1 antibody for binding to thymocytes3. The 53-6.7 antibody has been reported to block antigen presentation via MHC class I and inhibit T cell responses to IL-2. This antibody has also been used for depletion of CD8a+ cells. Additional reported applications (for the relevant formats) include: immunoprecipitation1,3, in vivo and in vitro cell depletion2,10,15, inhibition of CD8 T cell proliferation3, blocking of cytotoxicity3,4, immunohistochemical staining5,6 of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections, and spatial biology (IBEX)29,30. Clone 53-6.7 is not recommended for immunohistochemistry of formalin-fixed paraffin sections. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays or in vivo studies (Cat No. 100746).
Application References(PubMed link indicates BioLegend citation): Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IHC, IP) Hathcock KS. 1991. Current Protocols in Immunology. 3.4.1. (Deplete) Takahashi K, et al. 1992. P. Natl. Acad. Sci. USA 89:5557. (Block, IP) Ledbetter JA, et al. 1981. J. Exp. Med. 153:1503. (Block) Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC) Fan WY, et al. 2001. Exp. Biol. Med. 226:1045. (IHC) Shih FF, et al. 2006. J. Immunol. 176:3438. (FC) Kamimura D, et al. 2006. J. Immunol. 177:306. Bouwer HGA, et al. 2006. P. Natl. Acad. Sci. USA 103:5102. (FC, Deplete) Kao C, et al. 2005. Int. Immunol. 17:1607. PubMed Ko SY, et al. 2005. J. Immunol. 175:3309. (FC) PubMed Rasmussen JW, et al. 2006. Infect. Immun. 74:6590. PubMed Lee CH, et al. 2009. Clin. Cancer Res. PubMed Geiben-Lynn R, et al. 2008. Blood 112:4585. (Deplete) PubMed Kingeter LM, et al. 2008. J. Immunol. 181:6244. PubMed Guo Y, et al. 2008. Blood 112:480. PubMed Andrews DM, et al. 2008. J. Virol. 82:4931. PubMed Britschqui MR, et al. 2008. J. Immunol. 181:7681. PubMed Kenna TJ, et al. 2008. Blood 111:2091. PubMed Jordan JM, et al. 2008. Infect. Immun. 76:3717. PubMed Todd DJ, et al. 2009. J. Exp. Med. 206:2151. PubMed Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed Medyouf H, et al. 2010. Blood 115:1175. PubMed Riedl P, et al. 2009. J. Immunol. 183:370. PubMed Apte SH, et al. 2010. J. Immunol. 185:998. PubMed Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed Cui L, et al. 2015. J Control Release. 206:220. PubMed Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations: Kastenmüller K, et al. 2013. Infect Immun . 81:789. PubMed Quinn K, et al. 2013. J Immunol. 191:5085. PubMed Chuang H, et al. 2014. Nat Commun. 5:4602. PubMed Cabrera-Mora M, et al. 2016. J Immunol. 197: 2748 - 2761. PubMed Sun L, et al. 2021. Cancer Cell. 39:1361. PubMed Cha JH et al. 2018. Molecular cell. 71(4):606-620 . PubMed Miragaia RJ, et al. 2019. Immunity. 50:493. PubMed Chan LC, et al. 2019. J Clin Invest. 129:3324. PubMed Vono M, et al. 2020. Cell Reports. 28(7):1773-1784.e5.. PubMed Li T, et al. 2022. J Leukoc Biol. 112:845. PubMed Duhalde Vega M, et al. 2022. Sci Adv. 8:eabn6545. PubMed Deák P, et al. 2022. Cell Rep. 41:111563. PubMed Ou W, et al. 2023. Nat Commun. 14:392. PubMed Zhu S, et al. 2023. Theranostics. 13:1042. PubMed Wang X, et al. 2023. J Immunother Cancer. 11:. PubMed Agrafiotis A, et al. 2023. iScience. 26:106055. PubMed Ke F, et al. 2023. Elife. 12:. PubMed Tursi NJ, et al. 2023. Front Immunol. 14:1072810. PubMed Rege SV, et al. 2023. Commun Biol. 6:292. PubMed Battistello E, et al. 2023. Mol Cell. 83:1216. PubMed van Os BW, et al. 2023. Eur Heart J Open. 3:oead013. PubMed Tan X, et al. 2023. Adv Sci (Weinh). 10:e2206768. PubMed Palakurthi B, et al. 2023. Nat Commun. 14:2109. PubMed Zhou X, et al. 2023. Sci Rep. 13:6701. PubMed Bhaskar A, et al. 2023. iScience. 26:106644. PubMed Ajith A, et al. 2021. Front Immunol. 12:687715. PubMed Apte SH, et al. 2020. Clin Transl Immunology. 9:e1209. PubMed Collin R, et al. 2020. J Immunol. 205:133. PubMed Mills EL, et al. 2022. Cell Metab. 34:140. PubMed Koenig A, et al. 2022. Front Immunol. 12:791100. PubMed Chan WY, et al. 2022. Infect Immun. 90:e0084618a. PubMed Cha JH, et al. 2022. J Biol Chem. 298:101817. PubMed Qu L, et al. 2022. Cell. 185:1728. PubMed Tu J, et al. 2022. Cancer Sci. 113:2496. PubMed Kiani Shabestari S, et al. 2022. Cell Rep. 39:110961. PubMed Grégoire C, et al. 2022. Immunity. 55:1216. PubMed Yu Z, et al. 2022. Biomater Sci. 11:263. PubMed Al-Saafeen BH, et al. 2023. Front Immunol. 13:1017780. PubMed Zhao K, et al. 2023. Front Immunol. 14:1101769. PubMed Azevedo PO, et al. 2023. NPJ Vaccines. 8:15. PubMed Scherer S, et al. 2023. Nat Immunol. 24:501. PubMed Kuehm LM, et al. 2021. Cancer Immunol Res. 9:227. PubMed Khojandi N, et al. 2021. Cancer Immunol Res. 9:214. PubMed Elazar A, et al. 2022. Elife. 11:. PubMed Berube A, et al. 2022. Viruses. 14:. PubMed Kaczanowska S, et al. 2021. Cell. 184(8):2033-2052.e21. PubMed Hirako I, et al. 2016. Nat Commun. 7:13277. PubMed Singhal A, et al. 2014. Sci Transl Med. 6:263. PubMed Chen J, et al. 2008. Blood. 111:5163. PubMed Fu Z, et al. 2019. Cell Rep. 28:159. PubMed Hastings AK, et al. 2019. iScience. 13:339. PubMed Romain Bouziat et al. 2018. Cell host & microbe. 24(5):677-688 . PubMed Hong M, et al. 2021. Int J Mol Sci. 22:. PubMed Qi Z, et al. 2022. Nat Commun. 13:182. PubMed Spranger S, et al. 2013. Sci Transl Med. 26:200. PubMed Sanchez-Felipe L, et al. 2021. Nature. 590:320. PubMed Turner JS et al. 2018. Cell reports. 25(6):1395-1403 . PubMed Zhang P et al. 2019. Cell Rep. 27(11):3117-3123 . PubMed Liu QZ, et al. 2018. Front Immunol. 1.131944444. PubMed Wei H, et al. 2021. Malar J. 20:89. PubMed Rodriguez-García A, et al. 2021. Nat Commun. 12:877. PubMed Liang S, et al. 2022. Acta Pharm Sin B. 12:2494. PubMed Park JH, et al. 2022. STAR Protoc. 3:101607. PubMed Hirano KI, et al. 2021. eLife. 0.416666666666667. PubMed Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed Acharya N, et al. 2020. Immunity. 53(3):658-671.e6. PubMed Clement M, et al. 2016. PLoS Pathog. 12:e1006050. PubMed Zhou Y, et al. 2016. Acta Pharmacol Sin. 10.1038/aps.2016.102. PubMed Oyarce C, et al. 2018. Front Immunol. 8:1794. PubMed Jazowiecka-Rakus J, et al. 2021. Cancers (Basel). 13:. PubMed Liang Y, et al. 2020. J Immunol. 204:2984. PubMed Rao E, et al. 2021. Sci Immunol. 6:. PubMed He C, et al. 2020. Clin Transl Med. 10:e39. PubMed Isakova-Sivak I, et al. 2020. Vaccines (Basel). 8:00. PubMed Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed Lian G et al. 2018. eLife. 7 pii: e36158. PubMed Das S, et al. 2019. Oncogene. 383316. PubMed Wei SC, et al. 2019. Immunity. 50:1084. PubMed Guo X, et al. 2020. Nat Commun. 11:2177. PubMed Somerville TD, et al. 2020. eLife. 9:e53381.. PubMed Porsche CE, et al. 2021. JCI Insight. 6:. PubMed Joseph R, et al. 2021. Br J Cancer. 125:176. PubMed Inoue D, et al. 2021. Nat Genet. 53:707. PubMed Almshayakhchi R, et al. 2021. Front Oncol. 11:636977. PubMed Konrath KM, et al. 2022. Cell Rep. 38:110318. PubMed Enriquez AB, et al. 2022. iScience. 25:104305. PubMed Sugimoto C, et al. 2022. Elife. 11:. PubMed Yu AI, et al. 2020. Cell Rep. 107471:31. PubMed Marangoni F, et al. 2021. Cell. . PubMed Kitano M, et al. 2016. Proc Natl Acad Sci U S A. 113: 1044 - 1049. PubMed Ni P, et al. 2014. J Immunol . 193:1778. PubMed Hsu JM, et al. 2018. Nat Commun. 9:1908. PubMed Zhang X, et al. 2022. Cell Mol Gastroenterol Hepatol. 14:494. PubMed Zhang C, et al. 2021. Clin Transl Immunology. 10:e1310. PubMed Nagarajan D, et al. 2021. Immunol Cell Biol. 99:972. PubMed Cousin N, et al. 2021. Cancer Res. 81:4133. PubMed Jassinskaja M, et al. 2021. Cell Reports. 34(12):108894. PubMed Trotta E, et al. 2018. Nat Med. 24:1005. PubMed He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed Davidson S, et al. 2020. Cell Reports. 31(7):107628. PubMed Hiltensperger M, et al. 2021. Nat Immunol. 22:880. PubMed Enriquez AB, et al. 2022. iScience. 25:104305. PubMed Wang B, et al. 2022. Nat Commun. 13:3821. PubMed Len-Letelier RA, et al. 2020. Frontiers in Immunology. 11:583382. PubMed Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed Domingos-Pereira S, et al. 2019. Cancer Immunol Res. 7:621. PubMed Leonard JD et al. 2017. Immunity. 47(1):107-117 . PubMed Miska J et al. 2019. Cell reports. 27(1):226-237 . PubMed Snell LM, et al. 2018. Immunity. 49:678. PubMed Kang SJ, et al. 2022. Food Sci Anim Resour. 42:903. PubMed Muñoz NM, et al. 2022. Sci Rep. 12:14449. PubMed Li J, et al. 2021. Cell Commun Signal. 19:89. PubMed Soto-Díaz K, et al. 2021. Front Immunol. 12:734349. PubMed O'Brien S, Zhang M 2015. J Immunol. 195: 695-705. PubMed Zheng J, et al. 2020. bioRxiv. . PubMed Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed Imani J, et al. 2021. JCI Insight. 6:. PubMed Hanasoge Somasundara AV, et al. 2021. Cell Rep. 37:110099. PubMed Witkowski MT, et al. 2020. Cancer Cell. 37:867. PubMed Xu Z, et al. 2020. Cancer Immunol Res. 1354:8. PubMed Zhang C, et al. 2020. Cell Rep. 32:108206. PubMed Guldner IH, et al. 2020. Cell. 183(5):1234-1248.e25. PubMed Kräutler NJ, et al. 2020. Cell Reports. 30(4):997-1012.e6.. PubMed Flosbach M, et al. 2020. Cell Reports. 32(4):107957. PubMed Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed Fu Z, et al. 2021. Nat Commun. 12:4462. PubMed França TT, et al. 2021. JCI Insight. 6:. PubMed Shen M, et al. 2022. Nat Cancer. 3:60. PubMed Zheng J, et al. 2020. Nature. . PubMed Yan J, et al. 2020. Cell Rep. 107820:31. PubMed Walsh SM, et al. 2021. eLife. 10:00. PubMed Gough D, et al. 2014. Blood. 124:2252. PubMed Liu C et al. 2019. Immunity. 51(2):381-397 . PubMed Kubota S, et al. 2019. Nat Commun. 10:1653. PubMed Yang S, et al. 2022. J Exp Med. 219:. PubMed Li J, et al. 2013. Arch Immunol Ther Exp (Warsz). 61:237. PubMed Huang J, et al. 2014. J Immunol. 192:1972. PubMed Giampazolias E, et al. 2021. Cell. . PubMed Sadik A, et al. 2020. Cell. 1252:182. PubMed Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed Lebel MÈ, et al. 2020. Nat Commun. 3.051388889. PubMed Merlo LM, et al. 2020. Clin Pathol. 13:2632010X20951812. PubMed Wang Z, et al. 2021. Acta Pharm Sin B. 694:11. PubMed Martin MD, et al. 2020. Cell Rep. 31:107508. PubMed Burgener SS, et al. 2019. Cell Rep. 27:3646. PubMed Cianciaruso C, et al. 2020. Cell Reports. 27(10):3062-3080.e11.. PubMed Chan WY, et al. 2019. Infect Immun. 87:. PubMed Matsumura T, et al. 2022. Nat Commun. 13:7064. PubMed Hou Y, et al. 2021. Sci Transl Med. 13:. PubMed Ye Q, et al. 2022. NPJ Vaccines. 7:84. PubMed Zhou J, et al. 2022. Int J Oncol. 61: . PubMed Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed Yasuma K, et al. 2016. PLoS Pathog. 12: 1005372. PubMed Fang Y, et al. 2021. J Clin Invest. 131:00:00. PubMed Chakraborty M, et al. 2021. Cell Reports. 34(2):108609. PubMed Zhang J, et al. 2022. Biomater Res. 26:44. PubMed Jazowiecka-Rakus J, et al. 2020. Mol Ther Oncolytics. 18:335. PubMed Yokomizo-Nakano T, et al. 2020. Cancer Res. 80:2523. PubMed Shoji M, et al. 2012. PLoS One. 7:e30302. PubMed Baumann D, et al. 2020. Nat Commun. 1.969444444. PubMed Namkoong H, et al. 2018. PLoS Pathog. 14:e1006955. PubMed Sema Kurtulus et al. 2018. Immunity. 50(1):181-194 . PubMed Cantor DJ et al. 2019. Cell reports. 26(1):108-118 . PubMed Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed Koide S, et al. 2022. iScience. 25:103603. PubMed Wu Y, et al. 2015. J Immunol. 195: 2612-2623. PubMed Tsunekuni K, et al. 2020. J Clin Med. 9:00. PubMed Di Pilato M, et al. 2021. Cell. 184(17):4512-4530.e22. PubMed Pradhan K, et al. 2021. J Immunol. 206:2980. PubMed Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed Neckermann P, et al. 2021. Front Immunol. 12:761214. PubMed Chew HY, et al. 2020. Cell. 180(5):895-914. PubMed Lavoie S, et al. 2020. Gastroenterology. 158:1359. PubMed Ajith A, et al. 2019. FASEB J. 33:5220. PubMed Luo H, et al. 2019. Cell Rep. 26:945. PubMed Oh J, et al. 2021. Clin Cancer Res. 27:4781. PubMed Li H, et al. 2022. iScience. 25:104481. PubMed Bansal K, et al. 2017. Nat Immunol. 18:263-273. PubMed Tian T, et al. 2020. Cancer Immunol Res. 660:8. PubMed Lai NY, et al. 2020. Cell. 180:33:00. PubMed Zhang B, et al. 2021. Nature. 599:471. PubMed Guo Y, et al. 2021. Nat Immunol. 22:746. PubMed Yang FM, et al. 2022. Front Immunol. 13:918241. PubMed Chow AK, et al. 2021. Cellular and Molecular Gastroenterology and Hepatology. :. PubMed Guo S, et al. 2021. Frontiers in Immunology. 11:614667. PubMed Lynn GM, et al. 2020. Nat Biotechnol. 38:320. PubMed Lucas ED, et al. 2020. Cell Reports. 33(2):108258. PubMed Lei F, et al. 2012. J Vis Exp. 63: 3986. PubMed Kubli SP, et al. 2019. Nat Commun. 10:2678. PubMed Scheyltjens I, et al. 2022. Nat Protoc. 17:2354. PubMed Yang H, et al. 2022. Viruses. 14:. PubMed Bessell CA, et al. 2020. JCI Insight. 5:. PubMed Li H, et al. 2021. Signal Transduct Target Ther. 6:389. PubMed
RRID: AB_312752 (BioLegend Cat. No. 100713) AB_312753 (BioLegend Cat. No. 100714)
Structure: Ig superfamily, CD8α chain, 34 kD
Distribution: Most thymocytes, T cell subset, some NK cells, lymphoid dendritic cells
Function: Co-receptor for TCR
Ligand/Receptor: MHC class I molecule
Antigen References: 1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press. 2. Zamoyska R. 1994. Immunity 1:243. 3. Ellmeier W, et al. 1999. Annu. Rev. Immunol. 17:523.
Gene ID: 12525
UniProt: View information about CD8alpha on UniProt.org
Clone: 53-6.7
Regulatory Status: RUO
Other Names: T8, Lyt2, Ly-2
Isotype: Rat IgG2a, κ